FIELD: medicine; laboratory and molecular diagnostics; oncology; radiation therapy.
SUBSTANCE: invention relates to medicine, namely to laboratory and molecular diagnostics, oncology, and radiation therapy; it can be used for the prediction of efficiency of radiation therapy in children with diffuse brain stem tumor. Peripheral blood plasma is taken from a patient before radiation therapy, at different stages of the radiation therapy course, and after radiation therapy. At each stage of blood taking, using digital drop PCR (ddPCR), a concentration of a mutant form of BRAF(V600E) is determined. If the concentration of the mutant form of BRAF(V600E) is increased in the beginning of the radiation therapy course and is decreased to its end, then the efficiency of radiation therapy is predicted.
EFFECT: method provides a possibility of prediction of efficiency of radiation therapy in children with diffuse brain stem tumor due to determination of dynamics of levels of concentration of a mutant form of BRAF(V600E) during treatment.
3 cl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHODS OF DETECTING AND MONITORING CANCER BY PERSONALIZED DETECTION OF CIRCULATING TUMOR DNA | 2019 |
|
RU2811503C2 |
THERAPEUTIC COMBINATIONS CONTAINING RAF INHIBITOR AND ERK INHIBITOR | 2017 |
|
RU2774612C2 |
BRAF MUTATIONS ENSUING RESISTANCE TO BRAF INHIBITORS | 2011 |
|
RU2571930C2 |
METHOD FOR ANALYSIS OF SOMATIC MUTATIONS IN BRAF, NRAS AND KIT GENES USING LNA-BLOCKING MULTIPLEX PCR AND SUBSEQUENT HYBRIDIZATION WITH OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP) | 2017 |
|
RU2674338C1 |
RET INHIBITOR FOR USE IN THE TREATMENT OF CANCER WITH RET ALTERATION | 2019 |
|
RU2800951C2 |
METHOD FOR INDICATING THE EFFECTIVENESS OF COMBINED ADAPTIVE STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN MEN WITH MALIGNANT BRAIN GLIOMAS | 2023 |
|
RU2801419C1 |
CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
METHOD OF DIAGNOSTICS AND MONITORING OF COURSE OF CEREBRAL GLYOMAS | 2017 |
|
RU2656182C1 |
METHOD FOR DETECTION OF UNSTABLE EXTRACELLULAR DNA, AND DEVICE USING IT | 2019 |
|
RU2779746C2 |
USE OF POROUS FIBERS FOR OBTAINING BLOOD OR BLOOD DERIVATIVE DEPUTY IN BLOOD CELLS AND PLATELETS FROM EXTRACELLULAR VESICLES | 2019 |
|
RU2796378C2 |
Authors
Dates
2022-09-30—Published
2020-12-28—Filed